Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces
Tóm tắt
HIV transmission among people who inject drugs (PWID) is high in Yunnan and Guangxi provinces in southwest China. To address this epidemic, Population Services International (PSI) and four cooperating agencies implemented a comprehensive harm reduction model delivered through community-based drop-incenters (DiC) and peer-led outreach to reduce HIV risk among PWID. We used 2012 behavioral survey data to evaluate the effectiveness of this model for achieving changes in HIV risk, including never sharing needles or syringes, always keeping a clean needle on hand, HIV testing and counseling (HTC), and consistent condom use. We used respondent-driven sampling to recruit respondents. We then used coarsened exact matching (CEM) to match respondents during analysis to improve estimation of the effects of exposure to both DiC and outreach, only DiC, and only outreach, modeled using multivariable logistic regression. We found a significant relationship between participating in both peer-led DiC-based activities and outreach and having a new needle on hand (odds ratio (OR) 1.53, p < .05) and consistent condom use (OR 3.31, p < .001). We also found a significant relationship between exposure to DiC activities and outreach and HIV testing in Kunming (OR 2.92, p < .01) and exposure to peer-led outreach and HIV testing through referrals in Gejiu, Nanning, and Luzhai (OR 3.63, p < .05). A comprehensive harm reduction model delivered through peer-led and community-based strategies reduced HIV risk among PWID in China. Both DiC activities and outreach were effective in providing PWID behavior change communications (BCC) and HTC. HTC is best offered in settings like DiCs, where there is privacy for testing and receiving results. Outreach coverage was low, especially in Guangxi province where the implementation model required building the technical capacity of government partners and grassroot organizations. Outreach appears to be most effective for referring PWID into HTC, especially when DiC-based HTC is not available and increasing awareness of DiCs where PWID can receive more intensive BCC interventions.
Tài liệu tham khảo
Jia M, Luo H, Ma Y, Wang N, Smith K, Mei J, Lu R, Lu J, Fu L, Zhang Q: The HIV epidemic in Yunnan province, China, 1989–2007. J Acquir Immune Defic Syndr. 2010, 53 (1): S34-S40.
Ruan Y, Liang S, Zhu J, Li X, Pan SW, Liu Q, Song B, Wang Q, Xing H, Shao Y: Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China. Sex Transm Dis. 2013, 40 (4): 323-328. 10.1097/OLQ.0b013e31827fd4d4.
Ministry of Health of the People’s Republic of China: China AIDS response progress report.http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_CN_Narrative_Report[1].pdf,
Zhang L, Chow EP, Jing J, Zhuang X, Li X, He M, Sun H, Li X, Gorgens M, Wilson D, Wang L, Guo W, Li D, Cui Y, Wang L, Wang N, Wu Z, Wilson D: HIV prevalence in China: integration of surveillance data and a systematic review. Lancet Infect Dis. 2013, 13 (11): 955-963. 10.1016/S1473-3099(13)70245-7.
Xu J, Smith MK, Ding G, Chu J, Wang H, Li Q, Chang D, Wang G, Shang H, Jiang Y, Wang N: Drug use and sex work: competing risk factors for newly acquired HIV in Yunnan, China. PloS one. 2013, 8 (3): e59050-10.1371/journal.pone.0059050.
Wei L, Chen J, Rodolph M, Beauchamp G, Masse B, Li R, Wang S, Ruan Y, Liu S, Zhang L, Zhou F, Rose SM, Perdue T, Lai S, Shao Y, Jackson JB: HIV incidence, retention, and changes of high-risk behaviors among rural injection drug users in Guangxi China. Subst Abus. 2007, 27 (4): 53-61. 10.1300/J465v27n04_07.
Ministry of Health of People's Republic of China, UNAIDS, WHO: Estimates for the HIV/AIDS epidemic in China. 2011,http://www.unaids.org.cn/pics/20130521161757.pdf,
Qian HZ, Schumacher JE, Chen HT, Ruan YH: Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduct J. 2006, 3: 4-10.1186/1477-7517-3-4.
Li J, Ha T, Zhang C, Liu H: The Chinese government's response to drug use and HIV/AIDS: a review of policies and programs. Harm Reduct J. 2010, 7 (1): 1-6. 10.1186/1477-7517-7-1.
Rou K, Sullivan SG, Liu P, Wu Z: Scaling up prevention programmes to reduce the sexual transmission of HIV in China. Int J Epidemiol. 2010, 39 (2): ii38-ii46.
Yin W, Hao Y, Sun X, Gong X, Li F, Li J, Rou K, Sullivan SG, Wang C, Cao X: Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010, 39 (2): ii29-ii37.
Liu B, Sullivan SG, Wu Z: An evaluation of needle exchange programmes in China. AIDS. 2007, 21 (8): S123-S128.
USAID Health Policy Initiatives: China: leading the way - a comprehensive approach to HIV prevention, care, and treatment.http://www.healthpolicyinitiative.com/Publications/Documents/1470_1_ComprehensiveApproach_07_14_11_r12.pdf,
PEPFAR: China operational plan report FY 2010. Office of U.S. Global AIDS Coordinator. 2010
Johnston LG, Chen YH, Silva-Santisteban A, Raymond HF: An empirical examination of respondent driven sampling design effects among HIV risk groups from studies conducted around the world. AIDS Behav. 2013, 17 (6): 2202-2210. 10.1007/s10461-012-0394-8.
Heckathorn DD: Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002, 49 (1): 11-34. 10.1525/sp.2002.49.1.11.
Salganik MJ, Heckathorn DD: Sampling and estimation in hidden populations using respondent‒driven sampling. Sociol Methodo. 2004, 34 (1): 193-240. 10.1111/j.0081-1750.2004.00152.x.
Michael W, Spiller CC, Heckathorn D: RDSTAT: RDS analysis tool 7.1 user manual. 2012, Ithaca, NY: Cornell University
Stuart EA: Matching methods for causal inference: a review and a look forward. Stat Sci. 2010, 25 (1): 1-21. 10.1214/09-STS313.
Wells AR, Hamar B, Bradley C, Gandy WM, Harrison PL, Sidney JA, Coberley CR, Rula EY, Pope JE: Exploring robust methods for evaluating treatment and comparison groups in chronic care management programs. Popul Health Manag. 2013, 16 (1): 35-45. 10.1089/pop.2011.0104.
Shadish W, Cook T, Campbel D: Experimental and quasi-experimental designs for generalized causal inference. 2002, Boston: Houghton Mifflin
King G, Nielsen R, Coberley C, Pope JE, Wells A: Comparative effectiveness of matching methods for causal inference. 2011,http://gking.harvard.edu/files/gking/files/psparadox.pdf,
Blackwell M, Iacus S, King G, Porro G: CEM: coarsened exact matching in stata. Stata J. 2009, 9 (4): 524-546.
Haider AH, David JS, Zafar SN, Gueugniaud PY, Efron DT, Floccard B, Mackenzie EJ, Voiglio E: Comparative effectiveness of inhospital trauma resuscitation at a French trauma center and matched patients treated in the United States. Ann Surg. 2013, 258 (1): 178-183. 10.1097/SLA.0b013e31828226b6.
Wu Z, Luo W, Sullivan SG, Rou K, Lin P, Liu W, Ming Z: Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS. 2007, 21 (8): S115-S122.
Des Jarlais DC, Kling R, Hammett TM, Ngu D, Liu W, Chen Y, Binh KT, Friedmann P: Reducing HIV infection among new injecting drug users in the China-Vietnam cross border project. AIDS. 2007, S109-S114. Suppl 8
Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW: Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008, 12 (4 Suppl): S131-S141.
McCreesh N, Frost SD, Seeley J, Katongole J, Tarsh MN, Ndunguse R, Jichi F, Lunel NL, Maher D, Johnston LG: Evaluation of respondent-driven sampling. Epidemiology (Cambridge, Mass). 2012, 23 (1): 138-147. 10.1097/EDE.0b013e31823ac17c.
Wejnert C: An empirical test of respondent-driven sampling: point estimates, variance, degree measures, and out-of-equilibrium data. Sociol Methodol. 2009, 39 (1): 73-116. 10.1111/j.1467-9531.2009.01216.x.